Coinfection with Hepatitis C Virus and HIV: More than Double Trouble

被引:6
作者
Piroth, Lionel [1 ]
机构
[1] CHU Dijon, Dept Infectiol, F-21079 Dijon, France
关键词
ACTIVE ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; DISEASE PROGRESSION; T-CELLS; VIROLOGICAL SUPPRESSION; POSITIVE PATIENTS; VIRAL-HEPATITIS; HCV COINFECTION; COHORT; IMPACT;
D O I
10.1086/603558
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:623 / 625
页数:3
相关论文
共 34 条
[21]   Risk of Developing Specific AIDS-Defining Illnesses in Patients Coinfected with HIV and Hepatitis C Virus With or Without Liver Cirrhosis [J].
Monforte, Antonella d'Arminio ;
Cozzi-Lepri, Alessandro ;
Castagna, Antonella ;
Antinori, Andrea ;
De Luca, Andrea ;
Mussini, Cristina ;
Lo Caputo, Sergio ;
Arlotti, Massimo ;
Magnani, Giacomo ;
Pellizzer, Gianpietro ;
Maggiolo, Franco ;
Puoti, Massimo .
CLINICAL INFECTIOUS DISEASES, 2009, 49 (04) :612-622
[22]   Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response [J].
Moore, DM ;
Hogg, RS ;
Chan, K ;
Tyndall, M ;
Yip, B ;
Montaner, JSG .
AIDS, 2006, 20 (03) :371-377
[23]   Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy [J].
Palepua, Anita ;
Tyndall, Mark W. ;
Joy, Ruth ;
Kerr, Thomas ;
Wood, Evan ;
Press, Natasha ;
Hogg, Robert S. ;
Montaner, Julio S. G. .
DRUG AND ALCOHOL DEPENDENCE, 2006, 84 (02) :188-194
[24]  
Phillips AN, 2007, AIDS, V21, P1717, DOI 10.1097/QAD.0b013e32827038bf
[25]  
Piroth L, 2000, J VIRAL HEPATITIS, V7, P302
[26]   Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients oil HCV therapy [J].
Piroth, Lionel ;
Carrat, Fabrice ;
Larrat, Sylvie ;
Goderel, Isabelle ;
Martha, Benoit ;
Payan, Christopher ;
Lunel-Fabiani, Francoise ;
Bani-Sadr, Firouze ;
Perronne, Christian ;
Cacoub, Patrice ;
Pol, Stanislas ;
Morand, Patrice .
JOURNAL OF HEPATOLOGY, 2008, 49 (06) :892-898
[27]   Cirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniae [J].
Propst-Graham, Katie L. ;
Preheim, Laurel C. ;
Top, Elizabeth A. Vander ;
Snitily, Mary U. ;
Gentry-Nielsen, Martha J. .
BMC MICROBIOLOGY, 2007, 7 (1)
[28]   Level, phenotype and activation status of CD4+FoxP3+ regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus [J].
Rallon, N. I. ;
Lopez, M. ;
Soriano, V. ;
Garcia-Samaniego, J. ;
Romero, M. ;
Labarga, P. ;
Garcia-Gasco, P. ;
Gonzalez-Lahoz, J. ;
Benito, J. M. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 155 (01) :35-43
[29]   Influence of viral hepatitis on HIV infection [J].
Rockstroh, JK .
JOURNAL OF HEPATOLOGY, 2006, 44 :S25-S27
[30]   Hepatitis C virus infection in HIV type 1-infected individuals does not accelerate a decrease in the CD4+ cell count but does increase the likelihood of AIDS-defining events [J].
Stebbing, J ;
Waters, L ;
Mandalia, S ;
Bower, M ;
Nelson, M ;
Gazzard, B .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (06) :906-911